Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent.

[1]  M. Skobe,et al.  Activation of NF-κB by the Latent vFLIP Gene of Kaposi's Sarcoma-Associated Herpesvirus Is Required for the Spindle Shape of Virus-Infected Endothelial Cells and Contributes to Their Proinflammatory Phenotype , 2006, Journal of Virology.

[2]  E. Cesarman,et al.  NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. , 2006, Blood.

[3]  D. Ganem,et al.  KSHV infection and the pathogenesis of Kaposi's sarcoma. , 2006, Annual review of pathology.

[4]  D. Ganem,et al.  RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.

[5]  J. Vieira,et al.  Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. , 2004, Virology.

[6]  J. Hiscott,et al.  A requirement for NF-κB induction in the production of replication-competent HHV-8 virions , 2004, Oncogene.

[7]  Shou-Jiang Gao,et al.  Kaposi’s Sarcoma-Associated Herpesvirus Induction of Chromosome Instability in Primary Human Endothelial Cells , 2004, Cancer Research.

[8]  E. Cesarman,et al.  KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells , 2004, The Journal of experimental medicine.

[9]  B. Chandran,et al.  Concurrent Expression of Latent and a Limited Number of Lytic Genes with Immune Modulation and Antiapoptotic Function by Kaposi's Sarcoma-Associated Herpesvirus Early during Infection of Primary Endothelial and Fibroblast Cells and Subsequent Decline of Lytic Gene Expression , 2004, Journal of Virology.

[10]  D. Ganem,et al.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.

[11]  S. Howell,et al.  KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.

[12]  R. Sun,et al.  NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.

[13]  D. Ganem,et al.  Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.

[14]  M. Dahiya,et al.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells , 2003, Journal of Virology.

[15]  M. Eby,et al.  The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.

[16]  M. McMahon,et al.  De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells , 2002, Journal of Virology.

[17]  Frederick Y. Wu,et al.  Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.

[18]  B. Chandran,et al.  Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.

[19]  P. Moore,et al.  Kaposi's Sarcoma-Associated Herpesvirus LANA2 Is a B-Cell-Specific Latent Viral Protein That Inhibits p53 , 2001, Journal of Virology.

[20]  E. Cesarman,et al.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.

[21]  D. Ganem,et al.  Transcriptional Activation by the Product of Open Reading Frame 50 of Kaposi’s Sarcoma-Associated Herpesvirus Is Required for Lytic Viral Reactivation in B Cells , 1999, Journal of Virology.

[22]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Christian Stehlik,et al.  Nuclear Factor (NF)-κB–regulated X-chromosome–linked iap Gene Expression Protects Endothelial Cells from Tumor Necrosis Factor α–induced Apoptosis , 1998, The Journal of experimental medicine.

[24]  P. Moore,et al.  Kaposi's sarcoma (KS), KS-associated herpesvirus, and the criteria for causality in the age of molecular biology. , 1998, American journal of epidemiology.

[25]  A. Haase,et al.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells , 1997, Journal of virology.

[26]  E. Cesarman,et al.  Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. , 1996, Blood.

[27]  F. Sigaux,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.

[28]  D. Ganem,et al.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. , 2004, The Journal of clinical investigation.

[29]  R. Sun,et al.  NF-kappaB inhibits gammaherpesvirus lytic replication. , 2003, Journal of virology.

[30]  S. Howell,et al.  KSHV vFLIP binds to IKK-gamma to activate IKK. , 2003, Journal of cell science.